Aarti Pharmalabs Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	18,006	21,151	18,526	19,452	11,999	-
Revenue Growth (YoY)	-12.47%	14.17%	-4.76%	62.11%	-	-
Cost of Revenue	8,771	11,744	10,608	12,046	7,470	-
Gross Profit	9,235	9,407	7,918	7,406	4,529	-
Selling, General & Admin	1,752	1,658	1,463	1,349	852.03	-
Other Operating Expenses	3,303	3,105	2,598	2,637	1,608	0.05
Operating Expenses	6,046	5,632	4,790	4,611	2,881	0.05
Operating Income	3,189	3,775	3,128	2,795	1,648	-0.05
Interest Expense	-366.23	-268.96	-172.15	-210.52	-3.4	-
Interest & Investment Income	71.47	71.47	30.74	21.87	24.84	-
Currency Exchange Gain (Loss)	16.93	16.93	-	-	-	-
Other Non Operating Income (Expenses)	-91.8	12.72	12.52	1.85	-116.1	-
EBT Excluding Unusual Items	2,844	3,607	2,999	2,608	1,554	-0.05
Gain (Loss) on Sale of Investments	-	-	5.51	-	-	-
Gain (Loss) on Sale of Assets	0.08	0.08	0.19	-0.58	0.21	-
Pretax Income	2,817	3,607	3,005	2,608	1,554	-0.05
Income Tax Expense	679.15	882.85	835.9	672.78	331.29	-
Net Income	2,137	2,724	2,169	1,935	1,223	-0.05
Net Income to Common	2,137	2,724	2,169	1,935	1,223	-0.05
Net Income Growth	-14.27%	25.59%	12.10%	58.27%	-	-
Shares Outstanding (Basic)	91	91	91	91	91	0
Shares Outstanding (Diluted)	91	91	91	91	91	0
Shares Change (YoY)	0.10%	0.07%	0.01%	-	36150.40%	-
EPS (Basic)	23.59	30.06	23.93	21.35	13.49	-0.18
EPS (Diluted)	23.56	30.04	23.93	21.35	13.49	-0.18
EPS Growth	-14.33%	25.53%	12.08%	58.27%	-	-
Free Cash Flow	-	-704.76	607.5	1,480	-1,849	-
Free Cash Flow Per Share	-	-7.77	6.70	16.33	-20.40	-
Dividend Per Share	4.000	5.000	3.000	2.000	-	-
Dividend Growth	14.29%	66.67%	50.00%	-	-	-
Gross Margin	51.29%	44.47%	42.74%	38.07%	37.74%	-
Operating Margin	17.71%	17.85%	16.89%	14.37%	13.74%	-
Profit Margin	11.87%	12.88%	11.71%	9.95%	10.19%	-
Free Cash Flow Margin	-	-3.33%	3.28%	7.61%	-15.40%	-
EBITDA	4,019	4,539	3,804	3,421	2,069	-
EBITDA Margin	22.32%	21.46%	20.54%	17.58%	17.25%	-
D&A For EBITDA	829.85	764.05	676.32	625.43	421.19	-
EBIT	3,189	3,775	3,128	2,795	1,648	-0.05
EBIT Margin	17.71%	17.85%	16.89%	14.37%	13.74%	-
Effective Tax Rate	24.11%	24.48%	27.82%	25.80%	21.32%	-
Revenue as Reported	18,002	21,252	18,575	19,476	12,025	-
Advertising Expenses	-	26.39	64.11	51.61	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.